Clinical trial

De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

NCT07421141

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record trastuzumab Normalized identity: trastuzumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pertuzumab Normalized identity: pertuzumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Radical Surgery Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Adjuvant Systemic Therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-09-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

HER2-positive Breast Cancercandidate · MONDO: HER2 positive breast carcinoma

Early Breast Cancerunresolved

Interventions

PaclitaxelDRUG · verified · RxNorm: paclitaxel

trastuzumabDRUG · verified · RxNorm: trastuzumab

PertuzumabDRUG · verified · RxNorm: pertuzumab

DocetaxelDRUG · verified · RxNorm: docetaxel

carboplatinDRUG · verified · RxNorm: carboplatin

Radical SurgeryPROCEDURE

Adjuvant Systemic TherapyDRUG

Sponsors & collaborators

National Medical Research Radiological Centre of the Ministry of Health of Russialead sponsor

Mapped research locations

MoscowRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07421141 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.